Vaxcyte Files 8K - Entry Into Definitive Agreement >PCVX
Vaxcyte Inc. (PCVX) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 09, 2026. On October 9, 2026, Vaxcyte, Inc. ("Vaxcyte") consummated the sale and issuance of $575,000,000 aggregate principal amount of its 1.50% Convertible Senior Notes due 2032 (the "N